Greenwich Lifesciences Inc (GLSI)

May 02, 2026

(GLSI) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 02, 2026

Apr 30, 2026

Greenwich LifeSciences delays annual report filing - Investing.com UK

Apr 30, 2026

Apr 30, 2026

Greenwich LifeSciences delays annual report filing By Investing.com - Investing.com Australia

Apr 30, 2026

Apr 30, 2026

Greenwich LifeSciences Provides Update Regarding Form 10-K Filing - The Manila Times

Apr 30, 2026

Apr 30, 2026

Europe trial enrollment jump leaves Greenwich finalizing 10-K figures - Stock Titan

Apr 30, 2026

Apr 29, 2026

GLSI Stock Price, Quote & Chart | GREENWICH LIFESCIENCES INC (NASDAQ:GLSI) - ChartMill

Apr 29, 2026

Apr 28, 2026

Why did Greenwich LifeSciences stock soar pre-market today? - MSN

Apr 28, 2026

Apr 26, 2026

Why is GLSI stock rising today? - MSN

Apr 26, 2026

Apr 26, 2026

Greenwich LifeSciences receives Nasdaq notice regarding late Form 10-K filing - MSN

Apr 26, 2026

Apr 25, 2026

Greenwich LifeSciences (NASDAQ:GLSI) Cut to "Sell" at Wall Street Zen - MarketBeat

Apr 25, 2026

Apr 24, 2026

Analysts Offer Insights on Healthcare Companies: Greenwich LifeSciences (GLSI) and Actinogen Medical (OtherATGGF) - The Globe and Mail

Apr 24, 2026

Apr 24, 2026

GLSI Technical Analysis | Trend, Signals & Chart Patterns | GREENWICH LIFESCIENCES INC (NASDAQ:GLSI) - ChartMill

Apr 24, 2026

Apr 23, 2026

HC Wainwright Has Bearish Estimate for GLSI FY2026 Earnings - MarketBeat

Apr 23, 2026

Apr 23, 2026

ASCO 2026 to feature Greenwich LifeSciences research poster - Traders Union

Apr 23, 2026

Apr 23, 2026

Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026 - ChartMill

Apr 23, 2026

Apr 23, 2026

GLSI (Greenwich LifeSciences Inc.) reports narrow Q3 2025 EPS beat, shares climb 2.36 percent on positive investor sentiment.Hedge Fund Inspired Picks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 23, 2026

Apr 23, 2026

Breast cancer immunotherapy study lands ASCO 2026 poster slot - Stock Titan

Apr 23, 2026

Apr 22, 2026

Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing - ChartMill

Apr 22, 2026

Apr 22, 2026

H.C. Wainwright Maintains Greenwich LifeSciences(GLSI.US) With Buy Rating, Maintains Target Price $50 - Moomoo

Apr 22, 2026

Apr 22, 2026

Nasdaq flags Greenwich LifeSciences over delayed 2025 annual report - Stock Titan

Apr 22, 2026

Apr 21, 2026

(GLSI) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily

Apr 21, 2026

Apr 20, 2026

Why Did GLSI Stock Rise Pre-Market Today? - Stocktwits

Apr 20, 2026

Apr 20, 2026

Greenwich LifeSciences shares rise on breast cancer vaccine trial data By Investing.com - Investing.com Canada

Apr 20, 2026

Apr 20, 2026

Greenwich LifeSciences unveils preliminary FLAMINGO-01 open label data at AACR Meeting - Traders Union

Apr 20, 2026

Apr 20, 2026

Breast cancer immunotherapy shows 4x immune response in Phase III data - Stock Titan

Apr 20, 2026

Apr 18, 2026

Is Greenwich LifeSciences (GLSI) stock still attractive (Bullish Sentiment) 2026-04-18Stock Idea Sharing Hub - Xã Thanh Hà

Apr 18, 2026

Apr 16, 2026

Greenwich LifeSciences (GLSI) Stock Rule Based Trade (Investors Pile In) 2026-04-16Shared Buy Zones - Xã Châu Thành

Apr 16, 2026

Apr 15, 2026

Greenwich LifeSciences (GLSI) Stock Rights Issue (At Lows) 2026-04-15Scalping - UBND thành phố Hải Phòng

Apr 15, 2026

Apr 14, 2026

Greenwich Lifesciences Provides Clinical Trial and Pipeline Update - National Today

Apr 14, 2026

Apr 14, 2026

Greenwich LifeSciences reports Q1 cash balance of $10.5 million By Investing.com - Investing.com Australia

Apr 14, 2026

Apr 14, 2026

Strategic financing update revealed by Greenwich LifeSciences - Traders Union

Apr 14, 2026

Apr 14, 2026

Greenwich LifeSciences, Inc. Provides Financial Updates and Progress on FLAMINGO-01 Phase III Trial for Breast Cancer Immunotherapy GLSI-100 - Quiver Quantitative

Apr 14, 2026

Apr 14, 2026

Greenwich LifeSciences reports Q1 cash balance of $10.5 million - Investing.com

Apr 14, 2026

Apr 14, 2026

Greenwich LifeSciences Provides Update on Financing Strategy - ChartMill

Apr 14, 2026

Apr 14, 2026

Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Tuesday - MarketBeat

Apr 14, 2026

Apr 13, 2026

Portfolio Shifts: Can Greenwich LifeSciences Inc expand into new markets2026 Recap & Detailed Earnings Play Strategies - baoquankhu1.vn

Apr 13, 2026

Apr 10, 2026

Greenwich Lifesciences Inc expected to post a loss of 32 cents a shareEarnings Preview - TradingView

Apr 10, 2026

Apr 10, 2026

Aug Retail: Will Greenwich LifeSciences Inc benefit from current market trendsTrade Risk Assessment & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Will Greenwich LifeSciences Inc benefit from current market trends2026 Market Outlook & Weekly Hot Stock Watchlists - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

(GLSI) Risk Channels and Responsive Allocation - Stock Traders Daily

Apr 10, 2026

Apr 08, 2026

Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01 - ADVFN

Apr 08, 2026

Apr 08, 2026

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential - Sahm

Apr 08, 2026

Apr 07, 2026

Greenwich LifeSciences: 'Buy' On Recent Open-Label Data And Patent Claim - Seeking Alpha

Apr 07, 2026

Apr 07, 2026

Greenwich LifeSciences files patent claims for breast cancer therapy By Investing.com - Investing.com South Africa

Apr 07, 2026

Apr 07, 2026

Greenwich LifeSciences advances new patent claims after FLAMINGO-01 data show statistically significant immune response - Traders Union

Apr 07, 2026

Apr 07, 2026

Greenwich LifeSciences files patent claims for breast cancer therapy - Investing.com

Apr 07, 2026

Apr 07, 2026

Greenwich Lifesciences Provides Update On Patent Claims Potentially Doubling Gp2 Market Potential - TradingView

Apr 07, 2026